The International Society for CNS Clinical Trials and Methods (ISCTM) hosted its 2021 Autumn Conference from Sept 30 – October 2, at which several of Signant’s clinical science and medicine leaders presented posters during the Scientific Program. The research they showcased represents the broad array of therapeutic area expertise at Signant and reflects our commitment advancing CNS clinical science.

Peruse the posters below and learn more about some of the authors here.

  1. Monitoring of Scale Administration and Videography Improves Quality in a Study of a Rare Genetic Neuromuscular Disease
    • Signant authors: Marcela Roy, Petra Reksoprodjo, Dorin Ariton, Ekaterina Ivanova, Joan Busner
    • Download Poster
scientific poster illustrating how clinical review and monitoring improve data quality in rare genetic neuromuscular disease clinical trial
Click to enlarge
  1. Positive and Negative Symptom Predominance in the Screening Period in Acute Schizophrenia Trials: An Exploratory Analysis
scientific poster displaying results of analysis of positive and negative symptom predominance in schizophrenia clinical trials
Click to enlarge
  1. Impact of Protocol Design on Between Scale Discrepancies in Early AD Clinical Trials
scientific poster displaying results of research examining impact of protocol design on alzheimer's disease clinical outcome assessment scores
Click to enlarge
  1. Exploring Discordant Data in Dementia Clinical Trials
scientific poster illustrating results of research into discordant data in dementia clinical trials
Click to enlarge
  1. Assessing the Severity of Anxiety Symptoms at Study Entry into Acute Schizophrenia Clinical Trials
scientific poster assessing severity of anxiety symptoms at study entry in schizophrenia clinical trials
Click to enlarge
  1. Borderline across Borderlines: Regional Variations in Who Enters Clinical Trials
    • Signant Authors: Juliet Brown, Sayaka Machizawa, Rachel Berman, Gary Sachs
    • Download Poster
scientific poster about borderline personality disorder clinical trials research
Click to enlarge

Signant Health

Signant Health is the evidence generation company. We are focused on leveraging software, deep therapeutic and scientific knowledge, and operational expertise to consistently generate quality evidence for clinical studies across traditional, virtual, and hybrid trial models. For more than 20 years, over 400 sponsors and CROs of all sizes – including all of Top 20 pharma – have trusted Signant Health solutions for remote and site-based eCOA, eConsent, IRT, supply chain management, and data quality analytics.

Recent Posts

eCOA

The Case for Cognitive Assessments in Phase I Clinical Trials

Learn more
person completing cognitive testing in phase I clinical trial

Scientific Advisory

Myasthenia Gravis: Reducing Outcome Measures Variability in Clinical Trials

Learn more
Man with Myasthenia Gravis sitting at desk smiling

Data Analytics

Clinical Trial Data: Navigating Audit Trail Data Regulations and Accessibility Challenges 

Learn more

eCOA

Webinar Recap: Unleashing the Power of PROs Throughout Oncology Drug Development

Learn more

eCOA

7 eCOA Solution Design Recommendations: Applied Insights from Trial Sites and CRAs 

Learn more